ADAP - Adaptimmune Therapeutics plc (ADAP) Q4 2023 Earnings Call Transcript
2024-03-06 09:29:11 ET
Adaptimmune Therapeutics plc (ADAP)
Q4 2023 Earnings Conference Call
March 6, 2024 8:00 AM ET
Company Participants
Juli Miller - Investor Relations
Adrian Rawcliffe - Chief Executive Officer
Gavin Wood - Chief Financial Officer
John Lunger - Chief Patient Supply Officer
Jo Brewer - Chief Scientific Officer
Conference Call Participants
Graig Suvannavejh - Mizuho Securities
Jonathan Chang - Leerink Partners
Yanan Zhu - Wells Fargo Securities
Presentation
Operator
Hello and welcome to Adaptimmune's Fourth Quarter and Year-End Conference Call and Business Update.
I will now turn the call over to Juli Miller. Juli, please go ahead.
Juli Miller
Good morning, thank you for joining us. Welcome to our Q4 and full-year 2023 update and I refer you to our disclaimer here, as well as our forward-looking statements in this morning's press release.
For the prepared portion of the call, Adrian Rawcliffe, our CEO, is with us, and other members of our management team are available for Q&A....
Adaptimmune Therapeutics plc (ADAP) Q4 2023 Earnings Call Transcript